AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-4216308_ITM" title="Facts and information about Reyataz approved.(Products)">Reyataz approved.(Products)</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
Reyataz approved.(Products)
Reyataz (atazanavir sulfate) is the first once-daily protease inhibitor approved for the treatment of HIV-1 infection in ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Reyataz approved.(Products)(protease inhibitor approved for treatment of HIV...
- Magazine article from: Family Practice News August 1, 2003 700+ words
Reyataz (atazanavir sulfate) is the first once-daily protease inhibitor approved for the treatment of HIV-1 infection in combination with other antiretroviral agents. For more information, contact Bristol-Meyers Squibb Co., 212-546-4000, www.reyataz.com.
- Reyataz approved.(RXs)(treatment for human immunodeficiency virus )(Brief...
- Magazine article from: Chain Drug Review November 20, 2006 700+ words
The FDA has approved a 300-mg single-capsule formulation of Reyataz in combination therapy for adults with HIV-1 infection. Bristol-Myers Squibb Co. is the manufacturer.
- Bristol-Meyers Squibb Company Engages Topro, Inc. in Worldwide Year 2000 Project
- Press release article from: PR Newswire December 19, 1997 700+ words
...signed an agreement with Bristol-Meyers Squibb Company (NYSE: BMY) to provide Year...pilot plant project at the Bristol- Meyers Squibb multi-building facility in New Brunswick...February of 1998. The intent of Bristol-Meyers Squibb is to roll-out the worldwide program...
- Florida Health Agency, Bristol-Meyers Squibb Approve Deal.
- Newspaper article from: Knight Ridder/Tribune Business News September 6, 2001 700+ words
...deal with Pfizer Inc., Bristol-Meyers Squibb will offer disease management programs...Gov. Jeb Bush said. Bristol-Meyers Squibb's program aims to prevent and treat...spent $59.6 million on Bristol-Meyers Squibb products last year, according to AHCA...
- Bristol-Meyers Squibb's new drug approved. (Monopril)
- Magazine article from: Caribbean Business Estrada, Edgar July 25, 1991 700+ words
Bristol-Meyers Squibb's new drug approved The Federal...sodium), a new drug from Bristol-Meyers Squibb. According to Juan J. Acevedo...division general manager of Bristol-Meyers Squibb Puerto Rico Inc., this drug is...
- Bristol-Meyers Squibb acquires Acordis.(Nonwoven news: a look at what's going...
- Magazine article from: Nonwovens Industry May 1, 2004 700+ words
New York-based pharmaceutical company Bristol-Meyers Squibb has acquired Acordis Specialty Fibers from Acordis, a multinational group of businesses. The newly acquired business will be...
- BRISTOL-MEYERS SQUIBB REPORTS RESULTS
- Press release article from: PR Newswire January 16, 1992 700+ words
BRISTOL-MEYERS SQUIBB REPORTS RESULTS NEW YORK, Jan. 16 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) reported record sales and...
- OSI Pharmaceuticals grants Bristol-Meyers Squibb license for its DPIV...
- Magazine article from: Long Island Business News December 14, 2006 700+ words
Byline: Henry E. Powderly II OSI Pharmaceuticals Inc. on Thursday said it has granted Bristol-Meyers Squibb license to technology that the company can use to create a type-2 diabetes treatment. OSI's diabetes and obesity subsidiary...
- Xechem Settles Antitrust Lawsuit Against Bristol-Meyers Squibb for $4.2 Million.
- Press release article from: Business Wire December 20, 2005 700+ words
...Inc. (OTC BB: XKEM) Xechem International announced today that it has settled its antitrust lawsuit against Bristol-Meyers Squibb Co. for $4.2 million. Court files reveal that the case against Bristol-Meyers, which was brought in federal district...
- DuPont Pharmaceuticals.(to be purchased by Bristol-Meyers Squibb)(Brief Article)
- Magazine article from: Chemistry and Industry September 3, 2001 700+ words
The European Commission has cleared the acquisition of DuPont Pharmaceuticals by Bristol-Meyers Squibb, saying the acquisition will result in only a minor increment in market share and not change BMS's overall ranking.'
Source: HighBeam Research, Reyataz approved.(Products)